The Usefulness and Wellbeing of Tofacitinib in the Treatment of Alopecia Areata

    Lubna Khondker, Abida Sultana, Md Shirajul Islam Khan
    Image of study
    TLDR Tofacitinib is effective and safe for treating alopecia areata.
    The clinical trial conducted at the Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka from July 2018 to December 2019 involved 45 patients with patchy alopecia areata, alopecia totalis, and alopecia universalis. These patients were treated with Tofacitinib, a Janus kinase inhibitor, at 5mg twice daily for 6 months. The results showed that 84.6% of patients with patchy alopecia areata, 72.7% with alopecia totalis, and 62.5% with alopecia universalis experienced full hair regrowth. However, 24.4% of the patients experienced side effects such as nausea, headache, and high respiratory tract infection. The study concluded that Tofacitinib is an effective and safe treatment for alopecia areata.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 6 results

    Related Research

    9 / 9 results